REFILE-Bristol-Myers Squibb to pay $19.5 mln to settle off-label promotion case

WASHINGTON, Dec 8 (Reuters) - Drugmaker Bristol-Myers Squibb

Co will pay $19.5 million to resolve multi-state

allegations that it improperly promoted a schizophrenia

treatment for uses not approved...

Read more